Physical Status of OSA Patients

Completed

• Conditions: Obstructive Sleep Apnea Syndrome
• Interventions: Diagnostic Test: Evaluation

• Registration Number: NCT05051514
• Lead Sponsor: Okan University

Brief Summary

To investigate the differences in postural stability, anxiety/depression, and quality of life of the patients according to the severity of Obstructive Sleep Apnea Syndrome.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-18
• Study First Submitted: 2021-04-18
• Study First Submitted QC: 2021-09-20
• Study First Posted: 2021-09-21
• Primary Completion: 2022-04-30
• Study Completion: 2022-05-30
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-30
• Last Update Posted: 2022-07-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

• Age > 18 years old.
• Getting a diagnosis of OSAS with polysomnography.
• Agree to participate in the study.

Exclusion Criteria

• Having respiratory system disease (COPD, asthma, bronchiectasis, lung cancer, etc.).
• Sedative, hypnotic drug intake. Use of medical supplements such as diazepam.
• Hypothyroidism, acromegaly.
• Diagnosis of a psychiatric illness.
• Uncontrolled arrhythmia causing symptoms or hemodynamic impairment.
• Pulmonary edema. Pregnancy.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
No-Mild Severity OSAS	Evaluation	Mild sleep apnea: An Apnea-Hypopnea Index (AHI) of five to 14 events per hour.
Moderate to Severe OSAS	Evaluation	Moderate sleep apnea: An Apnea-Hypopnea Index (AHI) of 15 to 29 events per hour.Severe sleep apnea: An Apnea-Hypopnea Index (AHI) of 30 or more events per hour.

Primary Outcome Measures

Name	Time	Method
Postural stability	Day 1.	The 30 Seconds Sit to Stand Test is a method used to measure the lower extremity muscle strength and postural stability.

Secondary Outcome Measures

Name	Time	Method
Anxiety and depression	Day 1.	The Hospital Anxiety and Depression Scale (HADS) is a self-report scale developed to determine the risk levels of patients in terms of anxiety and depression. HADS consists of two subscales, one measuring anxiety, with seven items, and another measuring depression, with seven items, which score separately. Those with a score of 10 and above for the anxiety subscale and those with a score of 7 and above for the depression subscale are defined as high-risk patients.

Trial Locations

Locations (1)

Bitlis State Hospital; 🇹🇷 Bitlis, Turkey